AstraZeneca COVID-19 Vaccine

Registration for interest in the Sinopharm vaccine is now available. Register your interest.

What you need to know about AstraZeneca vaccine

The Oxford AstraZeneca (AstraZeneca) Covid-19 vaccine is a vaccine developed by Oxford University and AstraZeneca. It has been approved by the World Health Organisation for emergency use in the efforts against Covid-19.

What’s different about the AstraZeneca vaccine?

A modified adenovirus

It is made from a weakened common cold virus

This vaccine is made from modifying the adenovirus to contain genetic material shared by the coronavirus.

Normal fridge temperature

This vaccine is stored at normal fridge temperatures

AstraZeneca does not require special refrigeration, making it a more accessible vaccine especially for developing countries.

Normal fridge temperature

Developed by Oxford University

Vaccine was developed by two of Oxford University’s entities – Jenner Institute and Vaccitech.

Who is eligible for taking AstraZeneca?

Individuals aged 18 years and older, with no history of anaphylaxis.

What is the recommended dosage for administration?

According to WHO, the recommendation is two-dose with an interval of 8-12 weeks between first and second dose.

How safe is AstraZeneca?

Efficacy rate of 63% against symptomatic COVID-19 infection with longer dose intervals within the 8 to 12 weeks range associated with greater vaccine efficacy